Evidence map›Paper›PMID 36233676›Full record

ArticleJournal of clinical medicine2022

Identification of miRNAs Involved in Foetal Growth Restriction Due to Maternal Smoking during Pregnancy.

Eva Barrio, Alba Quirós, Diego Lerma-Puertas, José I Labarta, Ana Gascón-Catalán

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Obtaining miRNA from Saliva-Comparison of Sampling and Purification Methods.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eva BarrioFacultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, Spain.
Alba QuirósFacultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, Spain.
Diego Lerma-PuertasFacultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, Spain.
José I LabartaFacultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, Spain.
Ana Gascón-CatalánFacultad de Ciencias de la Salud, Universidad de Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0003-0335-0404
Universidad de Zaragoza · ES

Funding

Gobierno de Aragón B19-20R
6 · The paper itself

Abstract

introductionSmoking during pregnancy is associated with reduced foetal growth, amongst other effects. Epigenetic modification in the foetus and placenta during embryonic development as a result of changes in the function of miRNAs is one of the pathophysiological mechanisms responsible for this. This dysregulation may be due to environmental changes or toxins such as tobacco.

objectiveTo study the impact of smoking during pregnancy and its role in intrauterine growth restriction via hypermethylated miRNAs. MATERIALS AND

methodsThe differences in methylation patterns for miRNAs in umbilical cord blood from low-birth-weight newborns of smoking mothers were compared with those from normal-weight newborns using MedIP-seq (StarArray).

resultsSeven hypermethylated miRNAs were identified in the epigenetic study of cord blood from low-birth-weight newborns of smoking mothers in our sample. The miRNAs found to be hypermethylated were: MIR7-1, MIR3918, MIR1244-1, MIR4721, MIR25, MIR93, MIR3656.

conclusionIntrauterine exposure to tobacco induces hypermethylation-mediated miRNA silencing in low-birth-weight newborns by modifying the expression of factors involved in vascular development, growth, and adaptation to hypoxia.

Indexed as

epigenetic modificationsintrauterine growth restrictionmiRNAtobacco

Identifiers

PMID36233676
PMCPMC9571148
OpenAlexW4303709746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.